|
CIZ1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.412200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.362400E-02 |
| Normal-vs-Stage2 |
1.446790E-01 |
| Normal-vs-Stage3 |
1.641600E-01 |
| Normal-vs-Stage4 |
5.264800E-01 |
| Stage1-vs-Stage2 |
7.413000E-01 |
| Stage1-vs-Stage3 |
8.587600E-01 |
| Stage1-vs-Stage4 |
4.532000E-01 |
| Stage2-vs-Stage3 |
6.715600E-01 |
| Stage2-vs-Stage4 |
4.272600E-01 |
| Stage3-vs-Stage4 |
5.607600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.484760E-01 |
| Normal-vs-AfricanAmerican |
7.321400E-01 |
| Normal-vs-Asian |
5.326600E-01 |
| Caucasian-vs-AfricanAmerican |
2.481400E-01 |
| Caucasian-vs-Asian |
6.573200E-01 |
| AfricanAmerican-vs-Asian |
4.511200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.163600E-02 |
| Normal-vs-Female |
9.109500E-02 |
| Male-vs-Female |
6.274400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.279820E-01 |
| Normal-vs-Age(41-60Yrs) |
8.026300E-02 |
| Normal-vs-Age(61-80Yrs) |
1.694960E-01 |
| Normal-vs-Age(81-100Yrs) |
7.909900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.440000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.720600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.775200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.962000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.833200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.039200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.608000E-01 |
| Classical-VS-Follicular |
7.9754000000043E-05 |
| Classical-VS-Other |
4.099200E-01 |
| Classical-VS-Normal |
5.724600E-01 |
| Tall-VS-Follicular |
4.151800E-02 |
| Tall-VS-Other |
5.926200E-01 |
| Tall-VS-Normal |
4.002200E-01 |
| Follicular-VS-Other |
5.576000E-01 |
| Follicular-VS-Normal |
2.177200E-04 |
| Other-VS-Normal |
4.684400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.331600E-02 |
| Normal-vs-N1 |
2.216100E-02 |
| N0-vs-N1 |
2.588000E-01 |
|
|
